{
  "ptid_time": "126_S_4896_2012-08-08",
  "img_path": "/data/qiuhui/data/adni/images/126_S_4896/2012-08-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,990 mm³, 13.2% above the reference mean. With a Z-score of 0.31 (62.3th percentile), this represents normal volume ; hippocampal volume measures 7,819 mm³, 2.6% below the reference mean. With a Z-score of -0.26 (39.8th percentile), this represents normal volume ; whole brain volume measures 1,230,370 mm³, 8.4% above the reference mean. With a Z-score of 1.20 (88.4th percentile), this represents mild enlargement. ",
  "text_data": "Age is 68.1 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 30.0. MoCA: 17.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.95 SUVR (mild reduced); Total tau: 239.60 pg/mL (normal ); Phosphorylated tau: 21.23 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal and ventricular volumes are within normal ranges, but the MoCA score of 17 indicates significant cognitive impairment, while the MMSE of 30 is unexpectedly normal (possible ceiling effect or testing inconsistency). The presence of one APOE4 allele and mildly reduced AV45 (amyloid PET) suggests early amyloid pathology. The discrepancy between MMSE and MoCA raises concerns about possible early cognitive decline.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (given the MoCA impairment despite normal MMSE and imaging, with biomarker evidence of early amyloid deposition).  \n\n**Confidence:** **Medium** (due to the conflicting MMSE/MoCA results, but MoCA is more sensitive to early deficits, and AV45 supports amyloid pathology).",
  "timestamp": "2025-07-26T12:51:32.194278"
}